If Artemisinin Drugs Fail, What's Plan B?

+ See all authors and affiliations

Science  14 May 2010:
Vol. 328, Issue 5980, pp. 846
DOI: 10.1126/science.328.5980.846

You are currently viewing the summary.

View Full Text


If the current generation of artemisinin-based combination therapies (ACTs) should fail, does the world have a solid backup plan? The short answer: No. New funding has lured academics and pharmaceutical companies back to the malaria field after a decades-long drought. But drug development is a slow process, and the only compounds far enough along in the pipeline to quickly replace current ACTs are variations on the artemisinin theme. Whether they will kill resistant parasites is a big question.